Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab
Background. Pertuzumab disrupts heterodimerization between human epidermal growth factor receptor 2 (HER2) and epidermal growth factor receptor (EGFR), HER3, a
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2017
|
| In: |
Annals of oncology
Year: 2017, Volume: 28, Issue: 4, Pages: 761-768 |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdw695 |
| Online Access: | Verlag, LF, Volltext: http://dx.doi.org/10.1093/annonc/mdw695 Verlag, LF, Volltext: https://academic.oup.com/annonc/article/28/4/761/2837420 
|
| Author Notes: | S.M. Swain, A. Schneeweiss, L. Gianni, J.J. Gao, A. Stein, M. Waldron-Lynch, S. Heeson, M.S. Beattie, B. Yoo, J. Cortes & J. Baselga |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1576589056 | ||
| 003 | DE-627 | ||
| 005 | 20220814170951.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180620s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/annonc/mdw695 |2 doi | |
| 035 | |a (DE-627)1576589056 | ||
| 035 | |a (DE-576)506589056 | ||
| 035 | |a (DE-599)BSZ506589056 | ||
| 035 | |a (OCoLC)1341012060 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Swain, Sandra M. |e VerfasserIn |0 (DE-588)1136982418 |0 (DE-627)893903809 |0 (DE-576)491013728 |4 aut | |
| 245 | 1 | 0 | |a Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab |c S.M. Swain, A. Schneeweiss, L. Gianni, J.J. Gao, A. Stein, M. Waldron-Lynch, S. Heeson, M.S. Beattie, B. Yoo, J. Cortes & J. Baselga |
| 264 | 1 | |c 2017 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published: 05 January 2017 | ||
| 500 | |a Gesehen am 20.06.2018 | ||
| 520 | |a Background. Pertuzumab disrupts heterodimerization between human epidermal growth factor receptor 2 (HER2) and epidermal growth factor receptor (EGFR), HER3, a | ||
| 700 | 1 | |a Schneeweiss, Andreas |d 1961- |e VerfasserIn |0 (DE-588)109972554 |0 (DE-627)632849630 |0 (DE-576)327251859 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of oncology |d Amsterdam [u.a.] : Elsevier, 1990 |g 28(2017), 4, Seite 761-768 |h Online-Ressource |w (DE-627)320428796 |w (DE-600)2003498-2 |w (DE-576)098134345 |x 1569-8041 |7 nnas |a Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab |
| 773 | 1 | 8 | |g volume:28 |g year:2017 |g number:4 |g pages:761-768 |g extent:8 |a Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/annonc/mdw695 |x Verlag |x Resolving-System |y LF |3 Volltext |
| 856 | 4 | 0 | |u https://academic.oup.com/annonc/article/28/4/761/2837420 |x Verlag |y LF |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180620 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 109972554 |a Schneeweiss, Andreas |m 109972554:Schneeweiss, Andreas |d 910000 |d 910400 |e 910000PS109972554 |e 910400PS109972554 |k 0/910000/ |k 1/910000/910400/ |p 2 | ||
| 999 | |a KXP-PPN1576589056 |e 3013136529 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"2017"}],"person":[{"display":"Swain, Sandra M.","given":"Sandra M.","role":"aut","family":"Swain"},{"role":"aut","family":"Schneeweiss","display":"Schneeweiss, Andreas","given":"Andreas"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"8 S."}],"recId":"1576589056","title":[{"title_sort":"Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab","title":"Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab"}],"note":["Published: 05 January 2017","Gesehen am 20.06.2018"],"language":["eng"],"name":{"displayForm":["S.M. Swain, A. Schneeweiss, L. Gianni, J.J. Gao, A. Stein, M. Waldron-Lynch, S. Heeson, M.S. Beattie, B. Yoo, J. Cortes & J. Baselga"]},"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"320428796","part":{"extent":"8","issue":"4","text":"28(2017), 4, Seite 761-768","pages":"761-768","volume":"28","year":"2017"},"origin":[{"dateIssuedDisp":"1990-","publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford","dateIssuedKey":"1990","publisher":"Elsevier ; Kluwer ; Oxford Univ. Press"}],"disp":"Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumabAnnals of oncology","id":{"issn":["1569-8041"],"zdb":["2003498-2"],"eki":["320428796"]},"pubHistory":["1.1990 -"],"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"language":["eng"],"title":[{"subtitle":"official journal of the European Society for Medical Oncology","title_sort":"Annals of oncology","title":"Annals of oncology"}],"corporate":[{"display":"European Society for Medical Oncology","role":"isb"}]}],"id":{"eki":["1576589056"],"doi":["10.1093/annonc/mdw695"]}} | ||
| SRT | |a SWAINSANDRINCIDENCEA2017 | ||